z-logo
Premium
dUTP Pyrophosphatase, its appearance in extracellular compartment may serve as a potential biomarker for N ‐methyl‐ N' ‐nitro‐ N ‐nitrosoguanidine exposure in mammalian cells
Author(s) -
Wu Meiping,
Shen Jing,
Zhan Jinbiao,
Yu Yingnian
Publication year - 2006
Publication title -
proteomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.26
H-Index - 167
eISSN - 1615-9861
pISSN - 1615-9853
DOI - 10.1002/pmic.200500767
Subject(s) - carcinogen , microbiology and biotechnology , mutagenesis , carcinogenesis , biochemistry , methylnitronitrosoguanidine , biology , western blot , cell culture , dna damage , chemistry , mutation , dna , genetics , gene
Abstract The monofunctional alkylating agent N ‐methyl‐ N' ‐nitro‐ N ‐nitrosoguanidine (MNNG) is a model chemical widely used for studying the molecular events induced by the widespread environmental N ‐nitroso alkylating carcinogen. Many studies have focused on understanding MNNG‐induced mutagenesis and carcinogenesis. However, the search for specific indicators of MNNG exposure is still underway. In this study, we analyzed the proteins in culture medium of human amnion epithelial cells (FL cells) exposed to MNNG by 2‐DE followed by MALDI‐TOF MS, in the hope of finding a specific protein marker suitable for MNNG risk assessment. Image visualization and statistical analysis indicated that 12 spots appeared and 4 spots up‐regulated after MNNG exposure. Most of them were identified by MS. These proteins include nuclear isoform of dUTP pyrophosphatase (DUT‐N), phosphoglycerate mutase 1, heparan sulfate proteoglycan perlecan, etc. , which are involved in multiple cellular functions. Interestingly, 2‐DE and MS analyses of cell lysate exposed to MNNG revealed that DUT‐N was down‐regulated. The appearance of DUT‐N in culture medium and its down‐regulation in cell lysate was confirmed by Western blot. These data suggest that these proteins, especially DUT‐N, could be used as candidate biomarkers for monitoring MNNG exposure.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here